Regeneron Pharmaceuticals REGN Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Regeneron Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regeneron Pharmaceuticals's change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regeneron Pharmaceuticals's change in inventories?
- Regeneron Pharmaceuticals (REGN) reported change in inventories of -$26.6M in Q1 2026.
- How has Regeneron Pharmaceuticals's change in inventories changed year-over-year?
- Regeneron Pharmaceuticals's change in inventories decreased by 117.5% year-over-year, from $152.3M to -$26.6M.
- What is the long-term trend for Regeneron Pharmaceuticals's change in inventories?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's change in inventories has grown at a -14.8% compound annual growth rate (CAGR), from $525.6M to $277.4M.
- What does change in inventories mean?
- Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.